Vaccines potentially double as a shield against dementia
A study by Oxford University suggests that certain vaccines, particularly those containing the AS01 adjuvant like Shingrix and Arexvy, may reduce the risk of dementia by boosting the immune system and suppressing viruses, with potential implications for new prevention strategies. The research analyzed health records of 430,000 people and found a significant association between vaccination and decreased dementia diagnoses, though further studies are needed to confirm the mechanisms involved.
